NCT06275971View on ClinicalTrials.gov

Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

August 31, 2024

Conditions
Cardiac DiseasePreDiabetesDiabetes Mellitus
Interventions
DEVICE

Dexcom G6

Glycemic control was monitored using CGM data for seven days following cardiac surgery

DEVICE

SMBG or venous/arterial blood glucose

Glycemic control was monitored using SMBG or venous/arterial blood glucose data for seven days following cardiac surgery

Trial Locations (1)

03181

RECRUITING

Kangbuk Samsung Hospital, Seoul

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Kangbuk Samsung Hospital

OTHER

NCT06275971 - Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter